Landauer — Q1 FY2012 Earnings Presentation
10 slides from Landauer's earnings presentation, Feb 7, 2012
Slide 1: Fiscal 2012 First Quarter Results
LANDAUER, INC. Fiscal 2012 First Quarter Results February 7 th , 2012
Slide 2: Safe Harbor Statement
This presentation may contain forward - looking statements, including statements about the outlook and prospects for Company and industry growth, as well as statements about the Company’s future financial and operating performance . Some of the information shared here constitutes forward - looking s
Slide 3: First quarter revenue and operating income by segment
3 $23,904 $27,044 $4,534 $7,434 $2,191 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 Q1 2011 Q1 2012 $ m Revenues Radiation Monitoring Medical Physics Medical Products $8,585 $6,290 ($458) $893 $370 ($1,000) $1,000 $3,000 $5,000 $7,000 $9,000 Q1 2011 Q1 2012 $ m Operating Income Radiation
Slide 4: Landauer Strategy Overview
Value Creation Deliver Upside Growth 1. Optimize Core 2.Competitive Growth 3. Strategic Expansion Strategic Priorities Landauer Strategy Overview Strategic Expansion Optimize the Core Competitive Growth New Management in 2006 Restructure: Cost IT/ERP system upgrades OSL / InLight – new inter
Slide 5: The Radiation Safety Continuum
Therapeutic / Diagnostic Accessories Information Imaging Physics Therapy Physics Patient Monitoring Occupational Monitoring Consulting Strategic Expansion Existing Services with Penetration Opportunities* Complementary Adjacent Products / Services _____________________ (1) Average Revenue per Facili
Slide 6: Competitive Growth: Global Military Expansion Pursued
6 Competitive Growth Global Military Expansion Pursued Expanding application of next generation technology to pursue global military and first responder radiation monitoring markets The U.S. military has now issued orders totaling $17 million to upgrade the Army’s tactical dosimetry capabilities
Slide 7: Strategic Expansion: Medical Physics and IZI Medical
7 Strategic Expansion Medical Physics Medical Physics produced $7.4 million in revenues for first quarter 2012; Generated $0.9 million in Operating Income Results highlight ongoing efforts to refine the medical physics sales cycle and improve profitability Continued focus on driving growth and
Slide 8: Optimize the Core: Systems Initiative Update
8 Optimize the Core Systems Initiative Update On schedule to support “Go - Live” of the final phase of the project in fiscal 2012 Substantial expense will be incurred to support the successful launch of the system – $4.7 million ($3.1 million net of tax) of non - recurring expense spending in fi
Slide 9: Dividend Policy and Outlook
Dividend Policy and Outlook 9 Dividend Policy Board of Directors declared a regular quarterly cash dividend of $0.55 per share for the first quarter of fiscal 2012 – This represents an annual rate of $2.20 per share, consistent with fiscal 2011 levels – The dividend was paid on January 4, 2012 to
Slide 10: Fiscal 2012 First Quarter Results
Fiscal 2012 First Quarter Results February 7 th , 2012